Type II collagen oral tolerance; Mechanism and role in collagen-induced arthritis and rheumatoid arthritis

Modern Rheumatology

Volumn 19, Issue 6, 2009, Pages 581-589

  Park, Kyung Su ^a   Park, Min Jung ^a   Cho, Mi La ^a   Kwok, Seung Ki ^a   Ju, Ji Hyeon ^a   Ko, Hyeok Jae ^a   Park, Sung Hwan ^a   Kim, Ho Youn ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Collagen induced arthritis; Oral tolerance; Rheumatoid arthritis; Type II collagen

Indexed keywords

CD11B ANTIGEN; COLLAGEN TYPE 2; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; OSTEOCLAST DIFFERENTIATION FACTOR; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL TRIAL; DENDRITIC CELL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; GENE EXPRESSION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH17 CELL;

ADMINISTRATION, ORAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; COLLAGEN TYPE II; CYTOKINES; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 73349140174     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0210-0     Document Type: Review

References (99)

1. AM Faria HL Weiner 2005 Oral tolerance Immunol Rev 206 232 259 10.1111/j.0105-2896.2005.00280.x 1:CAS:528:DC%2BD2MXhtVWjsb%2FL 16048553 (Pubitemid 41105174)
2. L Mayer L Shao 2004 Therapeutic potential of oral tolerance Nat Rev Immunol 4 6 407 419 10.1038/nri1370 1:CAS:528:DC%2BD2cXksVaqsb4%3D 15173830
3. AM Mowat 2003 Anatomical basis of tolerance and immunity to intestinal antigens Nat Rev Immunol 3 4 331 341 10.1038/nri1057 1:CAS:528: DC%2BD3sXisFWku7s%3D 12669023
4. K Fujihashi T Dohi PD Rennert M Yamamoto T Koga H Kiyono, et al. 2001 Peyer's patches are required for oral tolerance to proteins Proc Natl Acad Sci USA 98 6 3310 3315 10.1073/pnas.061412598 1:CAS:528:DC%2BD3MXit1altr8%3D 11248075 (Pubitemid 32220842)
5. N Takayama O Igarashi MN Kweon H Kiyono 2007 Regulatory role of Peyer's patches for the inhibition of OVA-induced allergic diarrhea Clin Immunol 123 2 199 208 10.1016/j.clim.2007.01.007 1:CAS:528:DC%2BD2sXksV2ls7o%3D 17360239 (Pubitemid 46590069)
6. E Williamson JM Bilsborough JL Viney 2002 Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction J Immunol 169 7 3606 3612 1:CAS:528:DC%2BD38XnsFelsbo%3D 12244151
7. TW Spahn A Fontana AM Faria AJ Slavin HP Eugster X Zhang, et al. 2001 Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches Eur J Immunol 31 4 1278 1287 10.1002/1521-4141(200104)31: 4<1278::AID-IMMU1278>3.0.CO;2-A 1:CAS:528:DC%2BD3MXivFyjsLs%3D 11298355 (Pubitemid 32331633)
8. A Friedman HL Weiner 1994 Induction of anergy or active suppression following oral tolerance is determined by antigen dosage Proc Natl Acad Sci USA 91 14 6688 6692 10.1073/pnas.91.14.6688 1:CAS:528:DyaK2cXkvVSmtL4%3D 8022835 (Pubitemid 24200727)
9. JL Coombes F Powrie 2008 Dendritic cells in intestinal immune regulation Nat Rev Immunol 8 6 435 446 10.1038/nri2335 1:CAS:528:DC%2BD1cXmt1Ojt7w%3D 18500229 (Pubitemid 351733420)
10. DE Trentham AS Townes AH Kang 1977 Autoimmunity to type II collagen an experimental model of arthritis J Exp Med 146 3 857 868 10.1084/jem.146.3.857 1:STN:280:DyaE2s3ltFejtg%3D%3D 894190 (Pubitemid 8175993)
11. HS Thompson N Harper DJ Bevan NA Staines 1993 Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression Autoimmunity 16 3 189 199 10.3109/08916939308993327 1:STN:280:DyaK2c3ntF2iuw%3D%3D 8003614
12. SD Khare CJ Krco MM Griffiths HS Luthra CS David 1995 Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis J Immunol 155 7 3653 3659 1:CAS:528:DyaK2MXot1Ggtb4%3D 7561065
13. WU Kim WK Lee JW Ryoo SH Kim J Kim J Youn, et al. 2002 Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance Arthritis Rheum 46 4 1109 1120 10.1002/art.10198 1:CAS:528:DC%2BD38Xjs12ltLc%3D 11953991 (Pubitemid 34303826)
14. SY Min SY Hwang KS Park JS Lee KE Lee KW Kim, et al. 2004 Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen Arthritis Res Ther 6 3 R213 R219 10.1186/ar1169 1:CAS:528:DC%2BD2cXjvFGisrY%3D 15142267
15. SY Min KS Park ML Cho JW Kang YG Cho SY Hwang, et al. 2006 Antigen-induced, tolerogenic CD11c+, CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis Arthritis Rheum 54 3 887 898 10.1002/art.21647 1:CAS:528:DC%2BD28XjtV2lsLk%3D 16508971
16. G Garcia Y Komagata AJ Slavin R Maron HL Weiner 1999 Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen J Autoimmun 13 3 315 324 10.1006/jaut.1999.0320 1:STN:280: DC%2BD3c%2FhvFOmsQ%3D%3D 10550219
17. LK Myers DD Brand XJ Ye MA Cremer EF Rosloniec M Bodo, et al. 1998 Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice Immunology 95 4 631 639 10.1046/j.1365-2567.1998. 00637.x 1:CAS:528:DyaK1MXjtFChtg%3D%3D 9893056 (Pubitemid 28559158)
18. P Zhu XY Li HK Wang JF Jia ZH Zheng J Ding, et al. 2007 Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis Clin Immunol 122 1 75 84 10.1016/j.clim.2006.08.004 1:CAS:528:DC%2BD28Xhtlalt7bF 17045846 (Pubitemid 46026693)
19. SJ Khoury WW Hancock HL Weiner 1992 Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain J Exp Med 176 5 1355 1364 10.1084/jem.176.5.1355 1:CAS:528:DyaK38XmtFSmsLs%3D 1383385
20. Y Chen VK Kuchroo J Inobe DA Hafler HL Weiner 1994 Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis Science 265 5176 1237 1240 10.1126/science.7520605 1:CAS:528:DyaK2cXlslOms7w%3D 7520605
21. LM Santos A Al-Sabbagh A Londono HL Weiner 1994 Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice Cell Immunol 157 2 439 447 10.1006/cimm.1994.1240 1:CAS:528:DyaK2cXmtVeis7Y%3D 7520838 (Pubitemid 24278350)
22. M Polanski NS Melican J Zhang HL Weiner 1997 Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines J Autoimmun 10 4 339 346 10.1006/jaut.1997.0148 1:STN:280: DyaK2szotlWksQ%3D%3D 9237797 (Pubitemid 27366139)
23. GJ Thorbecke R Schwarcz J Leu C Huang WJ Simmons 1999 Modulation by cytokines of induction of oral tolerance to type II collagen Arthritis Rheum 42 1 110 118 10.1002/1529-0131(199901)42:1<110::AID-ANR14>3.0.CO;2-M 1:CAS:528:DyaK1MXosF2isA%3D%3D 9920021 (Pubitemid 29042577)
24. W Chen W Jin N Hardegen KJ Lei L Li N Marinos, et al. 2003 Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 12 1875 1886 10.1084/jem.20030152 1:CAS:528:DC%2BD3sXpvFaktLg%3D 14676299 (Pubitemid 38032120)
25. S Huber C Schramm HA Lehr A Mann S Schmitt C Becker, et al. 2004 Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+T cells J Immunol 173 11 6526 6531 1:CAS:528:DC%2BD2cXhtVShsLbK 15557141
26. M Pyzik CA Piccirillo 2007 TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets J Leukoc Biol 82 2 335 346 10.1189/jlb.1006644 1:CAS:528:DC%2BD2sXos12ru74%3D 17475784 (Pubitemid 47230645)
27. A Kitani I Fuss K Nakamura F Kumaki T Usui W Strober 2003 Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis J Exp Med 198 8 1179 1188 10.1084/jem.20030917 1:CAS:528:DC%2BD3sXosVGqt7s%3D 14557415 (Pubitemid 37323383)
28. H Fukaura SC Kent MJ Pietrusewicz SJ Khoury HL Weiner DA Hafler 1996 Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients J Clin Invest 98 1 70 77 10.1172/JCI118779 1:CAS:528:DyaK28XktFWgsb4%3D 8690806
29. K Nakamura A Kitani W Strober 2001 Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta J Exp Med 194 5 629 644 10.1084/jem.194.5.629 1:CAS:528:DC%2BD3MXms1KhsLo%3D 11535631 (Pubitemid 32844773)
30. S Yoshino 1998 Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen J Immunol 160 6 3067 3071 1:CAS:528:DyaK1cXhvVWqtLs%3D 9510213 (Pubitemid 28136765)
31. Y Morita J Yang R Gupta K Shimizu EA Shelden J Endres, et al. 2001 Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis J Clin Invest 107 10 1275 1284 10.1172/JCI11490 1:CAS:528:DC%2BD3MXjsl2ntrk%3D 11375417
32. SH Kim S Kim CH Evans SC Ghivizzani T Oligino PD Robbins 2001 Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4 J Immunol 166 5 3499 3505 1:CAS:528:DC%2BD3MXhs1OisL8%3D 11207309
33. DA Wolvers MJ van der Cammen G Kraal 1997 Mucosal tolerance is associated with, but independent of, up-regulation Th2 responses Immunology 92 3 328 333 10.1046/j.1365-2567.1997.00356.x 1:CAS:528:DyaK2sXntlCrt7Y%3D 9486104
34. M Walmsley PD Katsikis E Abney S Parry RO Williams RN Maini, et al. 1996 Interleukin-10 inhibition of the progression of established collagen-induced arthritis Arthritis Rheum 39 3 495 503 10.1002/art.1780390318 1:CAS:528:DyaK28Xit1Gks7o%3D 8607899 (Pubitemid 26085226)
35. LA Joosten E Lubberts P Durez MM Helsen MJ Jacobs M Goldman, et al. 1997 Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction Arthritis Rheum 40 2 249 260 10.1002/art.1780400209 1:CAS:528:DyaK2sXhvVers7Y%3D 9041936 (Pubitemid 27114088)
36. C Kemper AC Chan JM Green KA Brett KM Murphy JP Atkinson 2003 Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype Nature 421 6921 388 392 10.1038/nature01315 1:CAS:528:DC%2BD3sXlsVansQ%3D%3D 12540904 (Pubitemid 36157938)
37. AJ Slavin R Maron HL Weiner 2001 Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes Int Immunol 13 6 825 833 10.1093/intimm/13.6.825 1:CAS:528:DC%2BD3MXktlSrsrc%3D 11369711
38. K Sato A Suematsu K Okamoto A Yamaguchi Y Morishita Y Kadono, et al. 2006 Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction J Exp Med 203 12 2673 2682 10.1084/jem.20061775 1:CAS:528:DC%2BD28Xht12htLfJ 17088434 (Pubitemid 44833343)
39. JK Kolls A Linden 2004 Interleukin-17 family members and inflammation Immunity 21 4 467 476 10.1016/j.immuni.2004.08.018 1:CAS:528: DC%2BD2cXpvVygt7k%3D 15485625 (Pubitemid 39370503)
40. JH Ju ML Cho JY Jhun MJ Park HJ Oh SY Min, et al. 2008 Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis Immunol Lett 117 1 16 25 10.1016/j.imlet.2007.09.011 1:CAS:528:DC%2BD1cXjtlWgsbs%3D 18242716
41. BL Kelsall M Rescigno 2004 Mucosal dendritic cells in immunity and inflammation Nat Immunol 5 11 1091 1095 10.1038/ni1104-1091 1:CAS:528: DC%2BD2cXoslSksLk%3D 15496943 (Pubitemid 39549618)
42. A Iwasaki BL Kelsall 2000 Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine J Exp Med 191 8 1381 1394 10.1084/jem.191.8.1381 1:CAS:528: DC%2BD3cXislSitbo%3D 10770804 (Pubitemid 30227125)
43. A Iwasaki BL Kelsall 2001 Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells J Immunol 166 8 4884 4890 1:CAS:528:DC%2BD3MXivVKnu70%3D 11290765
44. A Castellaneta M Abe AE Morelli AW Thomson 2004 Identification and characterization of intestinal Peyer's patch interferon-alpha producing (plasmacytoid) dendritic cells Hum Immunol 65 2 104 113 10.1016/j.humimm.2003. 10.006 1:CAS:528:DC%2BD2cXht1Kmtbo%3D 14969765 (Pubitemid 38224136)
45. D Ehirchiou Y Xiong G Xu W Chen Y Shi L Zhang 2007 CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation J Exp Med 204 7 1519 1524 10.1084/jem.20062292 1:CAS:528:DC%2BD2sXnslymu7k%3D 17562817 (Pubitemid 47048019)
46. YO Jung SY Min ML Cho MJ Park JY Jeon JS Lee, et al. 2007 CD8alpha+ dendritic cells enhance the antigen-specific CD4 + T-cell response and accelerate development of collagen-induced arthritis Immunol Lett 111 2 76 83 10.1016/j.imlet.2007.05.005 1:CAS:528:DC%2BD2sXovFOjtr0%3D 17610959 (Pubitemid 47225129)
47. J Bilsborough TC George A Norment JL Viney 2003 Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties Immunology 108 4 481 492 10.1046/j.1365-2567. 2003.01606.x 1:CAS:528:DC%2BD3sXjtlylsLc%3D 12667210 (Pubitemid 36469686)
48. MG Roncarolo S Gregori M Battaglia R Bacchetta K Fleischhauer MK Levings 2006 Interleukin-10-secreting type 1 regulatory T cells in rodents and humans Immunol Rev 212 28 50 10.1111/j.0105-2896.2006.00420.x 1:CAS:528: DC%2BD28XpvFegtr4%3D 16903904 (Pubitemid 44116698)
49. F Fallarino U Grohmann S You BC McGrath DR Cavener C Vacca, et al. 2006 The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells J Immunol 176 11 6752 6761 1:CAS:528:DC%2BD28XkslWhsbs%3D 16709834
50. MJ Park SY Min KS Park YG Cho ML Cho YO Jung, et al. 2008 Indoleamine 2, 3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model Arthritis Res Ther 10 1 R11 10.1186/ar2361 18221522 (Pubitemid 351280044)
51. M Iwata A Hirakiyama Y Eshima H Kagechika C Kato SY Song 2004 Retinoic acid imprints gut-homing specificity on T cells Immunity 21 4 527 538 10.1016/j.immuni.2004.08.011 1:CAS:528:DC%2BD2cXpvVygtLw%3D 15485630 (Pubitemid 39370508)
52. AJ Stagg MA Kamm SC Knight 2002 Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin Eur J Immunol 32 5 1445 1454 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E 1:CAS:528:DC%2BD38XjvFKjsb4%3D 11981833 (Pubitemid 34546273)
53. WW Agace 2008 T-cell recruitment to the intestinal mucosa Trends Immunol 29 11 514 522 10.1016/j.it.2008.08.003 1:CAS:528:DC%2BD1cXht1KntLbE 18838302
54. JR Mora MR Bono N Manjunath W Weninger LL Cavanagh M Rosemblatt, et al. 2003 Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells Nature 424 6944 88 93 10.1038/nature01726 1:CAS:528:DC%2BD3sXltVelsLs%3D 12840763 (Pubitemid 36834847)
55. C Siewert A Menning J Dudda K Siegmund U Lauer S Floess, et al. 2007 Induction of organ-selective CD4+ regulatory T cell homing Eur J Immunol 37 4 978 989 10.1002/eji.200636575 1:CAS:528:DC%2BD2sXkvVSgsLw%3D 17345581 (Pubitemid 46925335)
56. SG Kang HW Lim OM Andrisani HE Broxmeyer CH Kim 2007 Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells J Immunol 179 6 3724 3733 1:CAS:528:DC%2BD2sXpvFKlsLg%3D 17785809
57. JL Coombes KR Siddiqui CV Arancibia-Carcamo J Hall CM Sun Y Belkaid, et al. 2007 A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism J Exp Med 204 8 1757 1764 10.1084/jem.20070590 1:CAS:528:DC%2BD2sXptVyjs7k%3D 17620361 (Pubitemid 47236314)
58. D Mucida Y Park G Kim O Turovskaya I Scott M Kronenberg, et al. 2007 Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid Science 317 5835 256 260 10.1126/science.1145697 1:CAS:528:DC%2BD2sXnsFaqt78%3D 17569825 (Pubitemid 47076203)
59. MJ Benson K Pino-Lagos M Rosemblatt RJ Noelle 2007 All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation J Exp Med 204 8 1765 1774 10.1084/jem.20070719 1:CAS:528:DC%2BD2sXptVyjs7Y%3D 17620363 (Pubitemid 47236315)
60. CM Sun JA Hall RB Blank N Bouladoux M Oukka JR Mora, et al. 2007 Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid J Exp Med 204 8 1775 1785 10.1084/jem.20070602 1:CAS:528:DC%2BD2sXptVyjs7c%3D 17620362 (Pubitemid 47236316)
61. TL Denning YC Wang SR Patel IR Williams B Pulendran 2007 Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses Nat Immunol 8 10 1086 1094 10.1038/ni1511 1:CAS:528:DC%2BD2sXhtVCkurnN 17873879 (Pubitemid 47423756)
62. JR Mora M Iwata B Eksteen SY Song T Junt B Senman, et al. 2006 Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells Science 314 5802 1157 1160 10.1126/science.1132742 1:CAS:528:DC%2BD28Xht1SmtrnI 17110582 (Pubitemid 44789048)
63. NM Tsuji A Kosaka 2008 Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells Trends Immunol 29 11 532 540 10.1016/j.it.2008.09.002 1:CAS:528:DC%2BD1cXht1KntLfM 18835746
64. S Sakaguchi T Yamaguchi T Nomura M Ono 2008 Regulatory T cells and immune tolerance Cell 133 5 775 787 10.1016/j.cell.2008.05.009 1:CAS:528: DC%2BD1cXntFaltrg%3D 18510923 (Pubitemid 351707693)
65. DA Vignali LW Collison CJ Workman 2008 How regulatory T cells work Nat Rev Immunol 8 7 523 532 10.1038/nri2343 1:CAS:528:DC%2BD1cXns1ehs7g%3D 18566595
66. D Dieckmann CH Bruett H Ploettner MB Lutz G Schuler 2002 Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected] J Exp Med 196 2 247 253 10.1084/jem.20020642 1:CAS:528:DC%2BD38XlsV2ms7g%3D 12119349 (Pubitemid 34787514)
67. LW Collison CJ Workman TT Kuo K Boyd Y Wang KM Vignali, et al. 2007 The inhibitory cytokine IL-35 contributes to regulatory T-cell function Nature 450 7169 566 569 10.1038/nature06306 1:CAS:528:DC%2BD2sXhtlCrtbzI 18033300 (Pubitemid 350190247)
68. PJ Coffer BM Burgering 2004 Forkhead-box transcription factors and their role in the immune system Nat Rev Immunol 4 11 889 899 10.1038/nri1488 1:CAS:528:DC%2BD2cXptFegtbw%3D 15516968 (Pubitemid 39490764)
69. KH Mills 2004 Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4 11 841 855 10.1038/nri1485 1:CAS:528:DC%2BD2cXptFegtLc%3D 15516964 (Pubitemid 39490760)
70. MC Fantini C Becker G Monteleone F Pallone PR Galle MF Neurath 2004 Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 J Immunol 172 9 5149 5153 1:CAS:528:DC%2BD2cXjt1Cks7s%3D 15100250
71. G Vlad R Cortesini N Suciu-Foca 2005 License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC J Immunol 174 10 5907 5914 1:CAS:528:DC%2BD2MXjvV2msLg%3D 15879080
72. L Cederbom H Hall F Ivars 2000 CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells Eur J Immunol 30 6 1538 1543 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X 1:CAS:528:DC%2BD3cXktFWmtLY%3D 10898488 (Pubitemid 30342794)
73. K Wing Y Onishi P Prieto-Martin T Yamaguchi M Miyara Z Fehervari, et al. 2008 CTLA-4 control over Foxp3+ regulatory T cell function Science 322 5899 271 275 10.1126/science.1160062 1:CAS:528:DC%2BD1cXht1Slu7%2FJ 18845758
74. CT Huang CJ Workman D Flies X Pan AL Marson G Zhou, et al. 2004 Role of LAG-3 in regulatory T cells Immunity 21 4 503 513 10.1016/j.immuni.2004.08.010 1:CAS:528:DC%2BD2cXpvVygtL4%3D 15485628 (Pubitemid 39370506)
75. CJ Workman DA Vignali 2003 The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells Eur J Immunol 33 4 970 979 10.1002/eji.200323382 1:CAS:528:DC%2BD3sXjtValurc%3D 12672063 (Pubitemid 36546685)
76. F Fallarino U Grohmann KW Hwang C Orabona C Vacca R Bianchi, et al. 2003 Modulation of tryptophan catabolism by regulatory T cells Nat Immunol 4 12 1206 1212 10.1038/ni1003 1:CAS:528:DC%2BD3sXpt1Sntrs%3D 14578884 (Pubitemid 37547898)
77. U Grohmann C Volpi F Fallarino S Bozza R Bianchi C Vacca, et al. 2007 Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy Nat Med 13 5 579 586 10.1038/nm1563 1:CAS:528:DC%2BD2sXkvVOhu7o%3D 17417651 (Pubitemid 46828479)
78. P Puccetti U Grohmann 2007 IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation Nat Rev Immunol 7 10 817 823 10.1038/nri2163 1:CAS:528:DC%2BD2sXhtVOrtbnN 17767193 (Pubitemid 47480306)
79. SJ Thompson HS Thompson N Harper MJ Day AJ Coad CJ Elson, et al. 1993 Prevention of pristane-induced arthritis by the oral administration of type II collagen Immunology 79 1 152 157 1:CAS:528:DyaK3sXkvFaqurk%3D 8509136
80. S Yoshino 1995 Downregulation of silicone-induced chronic arthritis by gastric administration of type II collagen Immunopharmacology 31 1 103 108 10.1016/0162-3109(95)00038-5 1:CAS:528:DyaK2MXpslKhtrg%3D 8655286
81. CH Ding Q Li ZY Xiong AW Zhou G Jones SY Xu 2003 Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis Clin Exp Immunol 132 3 416 423 10.1046/j.1365-2249.2003.02167.x 1:CAS:528:DC%2BD3sXlt12itLw%3D 12780687 (Pubitemid 36713947)
82. ML Barnett JM Kremer EW St Clair DO Clegg D Furst M Weisman, et al. 1998 Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial Arthritis Rheum 41 2 290 297 10.1002/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R 1:CAS:528:DyaK1cXhtlSmtL4%3D 9485087 (Pubitemid 28087697)
83. SF Ausar DM Beltramo LF Castagna S Quintana E Silvera G Kalayan, et al. 2001 Treatment of rheumatoid arthritis by oral administration of bovine tracheal type II collagen Rheumatol Int 20 4 138 144 10.1007/s002960100099 1:CAS:528:DC%2BD3MXkvFartL0%3D 11411957 (Pubitemid 32449110)
84. M Cazzola M Antivalle P Sarzi-Puttini D Dell'Acqua B Panni I Caruso 2000 Oral type II collagen in the treatment of rheumatoid arthritis. A six-month double blind placebo-controlled study Clin Exp Rheumatol 18 5 571 577 1:STN:280:DC%2BD3crhsVKktw%3D%3D 11072596
85. KM McKown LD Carbone SB Kaplan JA Aelion KM Lohr MA Cremer, et al. 1999 Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis Arthritis Rheum 42 6 1204 1208 10.1002/1529-0131(199906)42: 6<1204::AID-ANR17>3.0.CO;2-U 1:CAS:528:DyaK1MXktVegtL0%3D 10366113 (Pubitemid 29268957)
86. ML Barnett D Combitchi DE Trentham 1996 A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis Arthritis Rheum 39 4 623 628 10.1002/art.1780390413 1:CAS:528:DyaK28XivVegtLc%3D 8630112 (Pubitemid 26118041)
87. J Sieper S Kary H Sorensen R Alten U Eggens W Huge, et al. 1996 Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial Arthritis Rheum 39 1 41 51 10.1002/art.1780390106 1:CAS:528:DyaK28Xps12ksA%3D%3D 8546737 (Pubitemid 26036376)
88. DE Trentham RA Dynesius-Trentham EJ Orav D Combitchi C Lorenzo KL Sewell, et al. 1993 Effects of oral administration of type II collagen on rheumatoid arthritis Science 261 5129 1727 1730 10.1126/science.8378772 1:STN:280:DyaK3szptF2ksg%3D%3D 8378772
89. EH Choy DL Scott GH Kingsley S Thomas AG Murphy N Staines, et al. 2001 Control of rheumatoid arthritis by oral tolerance Arthritis Rheum 44 9 1993 1997 10.1002/1529-0131(200109)44:9<1993::AID-ART347>3.0.CO;2-A 1:CAS:528:DC%2BD3MXpt12lsbY%3D 11592359 (Pubitemid 33644040)
90. DG Hanson MJ Roy GM Green SD Miller 1993 Inhibition of orally-induced immune tolerance in mice by prefeeding an endopeptidase inhibitor Reg Immunol 5 2 76 84 1:STN:280:DyaK2c%2FjtFGitg%3D%3D 7692914
91. I Bjarnason P Williams A So GD Zanelli AJ Levi JM Gumpel, et al. 1984 Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs Lancet 2 8413 1171 1174 10.1016/S0140-6736(84)92739-9 1:STN:280:DyaL2M%2FlvFymuw%3D%3D 6150232
92. I Bjarnason G Zanelli T Smith P Prouse P Williams P Smethurst, et al. 1987 Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans Gastroenterology 93 3 480 489 1:STN:280:DyaL2s3nslagsw%3D%3D 3609658
93. WV Scheuer MV Hobbs WO Weigle 1987 Interference with tolerance induction in vivo by inhibitors of prostaglandin synthesis Cell Immunol 104 2 409 418 10.1016/0008-8749(87)90042-6 1:CAS:528:DyaL2sXhsFShsro%3D 2434247 (Pubitemid 17044719)
94. E Louis D Franchimont M Deprez A Lamproye N Schaaf P Mahieu, et al. 1996 Decrease in systemic tolerance to fed ovalbumin in indomethacin-treated mice Int Arch Allergy Immunol 109 1 21 26 10.1159/000237227 1:CAS:528:DyaK28XhsFKgsbg%3D 8527946
95. O Morteau 1999 COX-2: promoting tolerance Nat Med 5 8 867 868 10.1038/11301 1:CAS:528:DyaK1MXltVyjsL8%3D 10426302 (Pubitemid 29372403)
96. H Takagi T Hiroi L Yang K Takamura R Ishimitsu H Kawauchi, et al. 2008 Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed Vaccine 26 48 6027 6030 10.1016/j.vaccine.2008.09.019 1:CAS:528:DC%2BD1cXhtlGhu7jF 18822331
97. JB Sun S Raghavan A Sjoling S Lundin J Holmgren 2006 Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells J Immunol 177 11 7634 7644 1:CAS:528:DC%2BD28Xht1WrsL%2FO 17114433
98. S Bregenholt M Wang T Wolfe A Hughes L Baerentzen T Dyrberg, et al. 2003 The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes Scand J Immunol 57 5 432 438 10.1046/j.1365-3083.2003.01248.x 1:CAS:528:DC%2BD3sXksVOgtbc%3D 12753499 (Pubitemid 36577902)
99. N Kim KC Cheng SS Kwon R Mora M Barbieri TJ Yoo 2001 Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease Ann Otol Rhinol Laryngol 110 7 Pt 1 646 654 1:STN:280:DC%2BD3Mvhs1WrsA%3D%3D 11465824